다중 검출 면역측정법 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the global Multiplex Detection Immunoassay Market, offering an in-depth evaluation of market dynamics, including key growth drivers, restraints, opportunities, and emerging trends. This report serves as a valuable resource for industry stakeholders, providing insights into market potential, competitive landscape, and strategic recommendations for future growth.

Key Insights:

• Multiplex Detection Immunoassay Market Size (2025E): US$ 3.2 Bn
• Projected Market Value (2032F): US$ 4.4 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 4.4%

Multiplex Detection Immunoassay Market - Report Scope:

The multiplex detection immunoassay market refers to advanced diagnostic technologies that allow simultaneous detection and quantification of multiple biomarkers in a single assay. These assays are crucial in disease diagnostics, drug discovery, and biomedical research, offering high throughput, reduced reagent costs, and faster results. Growing prevalence of chronic and infectious diseases, combined with increased emphasis on early diagnosis and precision medicine, is enhancing the demand for multiplex technologies across clinical and research settings.

Market Growth Drivers:

The global multiplex detection immunoassay market is experiencing robust growth driven by rising incidences of chronic illnesses such as cancer, autoimmune diseases, and infectious conditions that require advanced diagnostics. The demand for cost-effective and high-throughput screening tools has propelled the adoption of multiplex assays in both clinical and research environments. Additionally, the shift towards personalized medicine and the need for efficient drug development processes are accelerating the use of multiplex technologies. Increased funding for R&D and growing collaborations between pharmaceutical companies and diagnostics firms are also contributing significantly to market expansion.

Market Restraints:

Despite its significant advantages, the multiplex detection immunoassay market faces several limitations. High initial investment costs and the complexity of assay development may hinder adoption, particularly among smaller laboratories and emerging economies. Technical challenges such as cross-reactivity and limited standardization across platforms can affect assay accuracy and reproducibility. Furthermore, regulatory hurdles associated with multiplex assay approval and commercialization add to the complexity of market entry for new players, restraining overall growth.

Market Opportunities:

The multiplex detection immunoassay market holds substantial opportunities, especially with technological advancements in assay design, microfluidics, and automation. Expansion into emerging markets such as South Asia, Latin America, and Africa, where healthcare infrastructure is rapidly evolving, provides a promising growth avenue. The increasing use of multiplex platforms in drug development and biomarker validation offers lucrative prospects for diagnostic and biotech firms. Strategic partnerships, continuous innovation, and the integration of AI and data analytics into assay interpretation are expected to create competitive advantages and unlock new application areas in the coming years.

Key Questions Answered in the Report:

• What are the main factors driving growth in the multiplex detection immunoassay market?
• Which technology and application segments are expected to lead during the forecast period?
• How are healthcare trends such as personalized medicine influencing market demand?
• Who are the key players in the global multiplex immunoassay space and what strategies are they adopting?
• What is the projected growth across different geographic regions?

Competitive Intelligence and Business Strategy:

Leading companies in the multiplex detection immunoassay market, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, QIAGEN, and Merck KGaA, are focusing on R&D investments and product innovation to enhance assay sensitivity and flexibility. Strategic collaborations with CROs and pharmaceutical companies are enabling better integration of multiplex assays in clinical trials and drug discovery pipelines. Furthermore, companies are expanding their global footprint through acquisitions, distribution partnerships, and entry into high-growth emerging markets. Emphasis on automation, miniaturization, and digital data analysis is further enhancing their competitive positioning.

Companies Covered in This Report:

• Meridian Bioscience
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• QIAGEN
• Bio-Techne
• DiaSorin S.p.A.
• BIOMERIEUX
• Quanterix
• Randox Laboratories Ltd.
• Merck KGaA
• Revvity
• F. Hoffmann-La Roche Ltd
• Sartorius AG
• Seegene Inc.
• BioGenex
• Miltenyi Biotec

Market Segmentation:

By Product:

• Instruments
• Kits & Reagents
• Software & Services

By Technique:

• Nucleic Acid Multiplex Assays
• Protein Multiplex Assays
• Cell-Based Multiplex Assays

By Technology:

• Flow Cytometry
• Multiplex Bead-Based Assay
• Luminescence
• Multiplex Real-Time PCR
• Others

By Application:

• Disease Diagnostics
• Research & Development
• Drug Discovery & Development
• Others

By End User:

• Pharmaceutical & Biotech Companies
• Clinical Research Organizations (CROs)
• Academic Research Institutes
• Diagnostic and Reference Laboratories
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Multiplex Detection Immunoassay Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Price Analysis, 2025A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product
• 4.4. Regional Prices and Product Preferences

5. Global Multiplex Detection Immunoassay Market Outlook

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Mn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 5.3. Global Multiplex Detection Immunoassay Market Outlook: Product
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
  • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 5.3.3.1. Instruments
    • 5.3.3.2. Kits & Reagents
    • 5.3.3.3. Software & Services
  • 5.3.4. Market Attractiveness Analysis: Product
• 5.4. Global Multiplex Detection Immunoassay Market Outlook: Technique
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Technique, 2019-2024
  • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
    • 5.4.3.1. Nucleic Acid Multiplex Assays
    • 5.4.3.2. Protein Multiplex Assays
    • 5.4.3.3. Cell-Based Multiplex Assays
  • 5.4.4. Market Attractiveness Analysis: Technique
• 5.5. Global Multiplex Detection Immunoassay Market Outlook: Technology
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2024
  • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 5.5.3.1. Flow Cytometry
    • 5.5.3.2. Multiplex Bead-Based Assay
    • 5.5.3.3. Luminescence
    • 5.5.3.4. Multiplex Real-Time PCR
    • 5.5.3.5. Others
  • 5.5.4. Market Attractiveness Analysis: Technology
• 5.6. Global Multiplex Detection Immunoassay Market Outlook: Application
  • 5.6.1. Introduction / Key Findings
  • 5.6.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
  • 5.6.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 5.6.3.1. Disease Diagnostics
    • 5.6.3.2. Research & Development
    • 5.6.3.3. Drug Discovery & Development
    • 5.6.3.4. Others
  • 5.6.4. Market Attractiveness Analysis: Application
• 5.7. Global Multiplex Detection Immunoassay Market Outlook: End User
  • 5.7.1. Introduction / Key Findings
  • 5.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 5.7.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 5.7.3.1. Pharmaceutical & Biotech Companies
    • 5.7.3.2. Clinical Research Organizations (CROs)
    • 5.7.3.3. Academic Research Institutes
    • 5.7.3.4. Diagnostic and Reference Laboratories
    • 5.7.3.5. Others
  • 5.7.4. Market Attractiveness Analysis: End User

6. Global Multiplex Detection Immunoassay Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Multiplex Detection Immunoassay Market Outlook

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Technique
  • 7.2.4. By Technology
  • 7.2.5. By Application
  • 7.2.6. By End User
• 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 7.4.1. Instruments
  • 7.4.2. Kits & Reagents
  • 7.4.3. Software & Services
• 7.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 7.5.1. Nucleic Acid Multiplex Assays
  • 7.5.2. Protein Multiplex Assays
  • 7.5.3. Cell-Based Multiplex Assays
• 7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 7.6.1. Flow Cytometry
  • 7.6.2. Multiplex Bead-Based Assay
  • 7.6.3. Luminescence
  • 7.6.4. Multiplex Real-Time PCR
  • 7.6.5. Others
• 7.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 7.7.1. Disease Diagnostics
  • 7.7.2. Research & Development
  • 7.7.3. Drug Discovery & Development
  • 7.7.4. Others
• 7.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.8.1. Pharmaceutical & Biotech Companies
  • 7.8.2. Clinical Research Organizations (CROs)
  • 7.8.3. Academic Research Institutes
  • 7.8.4. Diagnostic and Reference Laboratories
  • 7.8.5. Others
• 7.9. Market Attractiveness Analysis

8. Europe Multiplex Detection Immunoassay Market Outlook

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Technique
  • 8.2.4. By Technology
  • 8.2.5. By Application
  • 8.2.6. By End User
• 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 8.4.1. Instruments
  • 8.4.2. Kits & Reagents
  • 8.4.3. Software & Services
• 8.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 8.5.1. Nucleic Acid Multiplex Assays
  • 8.5.2. Protein Multiplex Assays
  • 8.5.3. Cell-Based Multiplex Assays
• 8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 8.6.1. Flow Cytometry
  • 8.6.2. Multiplex Bead-Based Assay
  • 8.6.3. Luminescence
  • 8.6.4. Multiplex Real-Time PCR
  • 8.6.5. Others
• 8.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 8.7.1. Disease Diagnostics
  • 8.7.2. Research & Development
  • 8.7.3. Drug Discovery & Development
  • 8.7.4. Others
• 8.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.8.1. Pharmaceutical & Biotech Companies
  • 8.8.2. Clinical Research Organizations (CROs)
  • 8.8.3. Academic Research Institutes
  • 8.8.4. Diagnostic and Reference Laboratories
  • 8.8.5. Others
• 8.9. Market Attractiveness Analysis

9. East Asia Multiplex Detection Immunoassay Market Outlook

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Technique
  • 9.2.4. By Technology
  • 9.2.5. By Application
  • 9.2.6. By End User
• 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 9.4.1. Instruments
  • 9.4.2. Kits & Reagents
  • 9.4.3. Software & Services
• 9.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 9.5.1. Nucleic Acid Multiplex Assays
  • 9.5.2. Protein Multiplex Assays
  • 9.5.3. Cell-Based Multiplex Assays
• 9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 9.6.1. Flow Cytometry
  • 9.6.2. Multiplex Bead-Based Assay
  • 9.6.3. Luminescence
  • 9.6.4. Multiplex Real-Time PCR
  • 9.6.5. Others
• 9.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 9.7.1. Disease Diagnostics
  • 9.7.2. Research & Development
  • 9.7.3. Drug Discovery & Development
  • 9.7.4. Others
• 9.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.8.1. Pharmaceutical & Biotech Companies
  • 9.8.2. Clinical Research Organizations (CROs)
  • 9.8.3. Academic Research Institutes
  • 9.8.4. Diagnostic and Reference Laboratories
  • 9.8.5. Others
• 9.9. Market Attractiveness Analysis

10. South Asia & Oceania Multiplex Detection Immunoassay Market Outlook

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Technique
  • 10.2.4. By Technology
  • 10.2.5. By Application
  • 10.2.6. By End User
• 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 10.4.1. Instruments
  • 10.4.2. Kits & Reagents
  • 10.4.3. Software & Services
• 10.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 10.5.1. Nucleic Acid Multiplex Assays
  • 10.5.2. Protein Multiplex Assays
  • 10.5.3. Cell-Based Multiplex Assays
• 10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 10.6.1. Flow Cytometry
  • 10.6.2. Multiplex Bead-Based Assay
  • 10.6.3. Luminescence
  • 10.6.4. Multiplex Real-Time PCR
  • 10.6.5. Others
• 10.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 10.7.1. Disease Diagnostics
  • 10.7.2. Research & Development
  • 10.7.3. Drug Discovery & Development
  • 10.7.4. Others
• 10.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.8.1. Pharmaceutical & Biotech Companies
  • 10.8.2. Clinical Research Organizations (CROs)
  • 10.8.3. Academic Research Institutes
  • 10.8.4. Diagnostic and Reference Laboratories
  • 10.8.5. Others
• 10.9. Market Attractiveness Analysis

11. Latin America Multiplex Detection Immunoassay Market Outlook

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Technique
  • 11.2.4. By Technology
  • 11.2.5. By Application
  • 11.2.6. By End User
• 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 11.4.1. Instruments
  • 11.4.2. Kits & Reagents
  • 11.4.3. Software & Services
• 11.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 11.5.1. Nucleic Acid Multiplex Assays
  • 11.5.2. Protein Multiplex Assays
  • 11.5.3. Cell-Based Multiplex Assays
• 11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 11.6.1. Flow Cytometry
  • 11.6.2. Multiplex Bead-Based Assay
  • 11.6.3. Luminescence
  • 11.6.4. Multiplex Real-Time PCR
  • 11.6.5. Others
• 11.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 11.7.1. Disease Diagnostics
  • 11.7.2. Research & Development
  • 11.7.3. Drug Discovery & Development
  • 11.7.4. Others
• 11.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.8.1. Pharmaceutical & Biotech Companies
  • 11.8.2. Clinical Research Organizations (CROs)
  • 11.8.3. Academic Research Institutes
  • 11.8.4. Diagnostic and Reference Laboratories
  • 11.8.5. Others
• 11.9. Market Attractiveness Analysis

12. Middle East & Africa Multiplex Detection Immunoassay Market Outlook

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Product
  • 12.2.3. By Technique
  • 12.2.4. By Technology
  • 12.2.5. By Application
  • 12.2.6. By End User
• 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  • 12.4.1. Instruments
  • 12.4.2. Kits & Reagents
  • 12.4.3. Software & Services
• 12.5. Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025-2032
  • 12.5.1. Nucleic Acid Multiplex Assays
  • 12.5.2. Protein Multiplex Assays
  • 12.5.3. Cell-Based Multiplex Assays
• 12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
  • 12.6.1. Flow Cytometry
  • 12.6.2. Multiplex Bead-Based Assay
  • 12.6.3. Luminescence
  • 12.6.4. Multiplex Real-Time PCR
  • 12.6.5. Others
• 12.7. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  • 12.7.1. Disease Diagnostics
  • 12.7.2. Research & Development
  • 12.7.3. Drug Discovery & Development
  • 12.7.4. Others
• 12.8. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 12.8.1. Pharmaceutical & Biotech Companies
  • 12.8.2. Clinical Research Organizations (CROs)
  • 12.8.3. Academic Research Institutes
  • 12.8.4. Diagnostic and Reference Laboratories
  • 12.8.5. Others
• 12.9. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Meridian Bioscience
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Product
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Thermo Fisher Scientific Inc.
  • 13.3.3. Bio-Rad Laboratories, Inc.
  • 13.3.4. QIAGEN
  • 13.3.5. Bio-Techne
  • 13.3.6. DiaSorin S.p.A.
  • 13.3.7. BIOMERIEUX
  • 13.3.8. Quanterix
  • 13.3.9. Randox Laboratories Ltd.
  • 13.3.10. Merck KGaA
  • 13.3.11. Revvity
  • 13.3.12. F. Hoffmann-La Roche Ltd
  • 13.3.13. Sartorius AG
  • 13.3.14. Seegene Inc.
  • 13.3.15. BioGenex
  • 13.3.16. Miltenyi Biotec
  • 13.3.17. SouthernBiotech
  • 13.3.18. Healgen
  • 13.3.19. Sepmag
  • 13.3.20. Curiox Biosystems
  • 13.3.21. MESO SCALE DIAGNOSTICS, LLC
  • 13.3.22. Wuxi NEST Biotechnology Co.,Ltd

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations